As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

Dr Reddy's CFO Narasimham recently told to Moneycontrol he is confident of 'sustained double-digit sales growth' in FY26, ...

ICICI Securities recommended hold rating on Natco Pharma with a target price of Rs 890 in its research report dated May 30, ...

Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent these effects. Effective treatments are available for managing “Ozempic face.” ...

Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

BioAge Labs, Inc. (NASDAQ:BIOA), a clinical-stage biotech innovator, announced today the completion of IND-enabling studies ...

Teachers' union, school officials clash over Armstrong School District budget, proposed tax hikes and teacher furloughs.

Researchers have found in a new cohort study that semaglutide offers significant protection against osteoporosis and gout in ...

Maximum walking distance at 52 weeks was significantly improved with semaglutide. 2. There were fewer treatment-related serious adverse events in the semaglutide group compared to placebo. Evidence Ra ...

The liver has a unique structure, especially at the level of individual cells. Hepatocytes, the main liver cells, release ...

IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical obesity models, both as monotherapy and in combination with GLP-1 receptor ...